When analyzing the MFI data, the level of CD159a expression decreased gradually, as expected (14) from the immature (CD56bright) towards the hypermature (CD56dim) NK subset in all three groups of cases: NBM, MDS, and AML. This evidence concerns the gene KLRC1 and myelodysplastic syndrome.